Product Description: Elinogrel (PRT060128) potassium is a reversible, competitive and orally active P2Y12 antagonist. Elinogrel potassium inhibits thrombosis[1][2].
Applications: COVID-19-immunoregulation
Formula: C20H15ClFKN5O5S2
References: [1]Ueno M, et al. Elinogrel: pharmacological principles, preclinical and early phase clinical testing. Future Cardiol. 2010 Jul;6(4):445-53./[2]Haberstock-Debic H, et al. A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist. J Pharmacol Exp Ther. 2011 Oct;339(1):54-61.
CAS Number: 936501-01-8
Molecular Weight: 563.04
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: P2Y Receptor